| | Class 2 Device Recall CellDyn |  |
| Date Initiated by Firm | June 16, 2004 |
| Date Posted | July 20, 2004 |
| Recall Status1 |
Terminated 3 on August 11, 2004 |
| Recall Number | Z-1112-04 |
| Recall Event ID |
29434 |
| Product Classification |
Counter, Cell, Automated (Particle Counter) - Product Code GKL
|
| Product | Cell-Dyn 1000 series platelet analyzer (model numbers 1300, 1400, 1600, 1700, 1800) |
| Code Information |
List numbers 91361-01,-03 (CD1300), 91360-03 (CD1300), 91336-01,-03 (CD 1400), 91377-01,-03 (CD 1400 CS), 91338-01, -03 (CD 1400 w/ RS232), 91339-01,-03 (CD 1400 CS w/ RS232) 91373-01, -03 (CD1600 CS 220v), 91375-01,-03 (CD 1600 CS 220v), 91374-01, -03 (CD 1600 CS120v), 91372-01,-03 (CD 1600 CS120v) 03H57-01, -03 (CD 1700 CS), 03H53-01, -03 (CD 1700), 07H77-01 (CD1800)-- 510k: 13/1400: K903665/A, 16/1700: K870233, 1800: K030513 |
| FEI Number |
2919069
|
Recalling Firm/ Manufacturer |
Abbott Laboratories
5440 Patrick Henry Dr
Santa Clara
CA
95054-1113
|
| For Additional Information Contact | John Dean 408-567-3430 |
Manufacturer Reason for Recall | Analyzer may generate inaccurate PLT concentration counts which may result in overestimation of true PLT concentration. |
FDA Determined Cause 2 | Other |
| Action | Correction letters and reply forms sent to clients on June 16, 2004, and a software update for the Cell-Dyn 1700 and 1800 series. An additional page to be inserted into user manuals for older models is included. No software update is planned for the older models. |
| Quantity in Commerce | currently unknown |
| Distribution | There are a total of 8107 US accounts, 53 government and 8054 private accounts. There are an unknown number of foreign consignees |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 �7.55.
|
|
|
|